ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Medications for Weight Loss: The New Satiety Hormones

Scripps Health

K. Fujioka

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

Tirzepatide Updates

Diana Isaacs

Weightloss in Menopause

Susan Brian

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

Tirzepatide for Type 2 Diabetes

Diana Isaacs

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Type 2 Diabetes - Medical Management

Michigan Medicine

A. Rothberg

Obesity: New Understanding and Treatments

Norman Lepor

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Jennifer Rosselli

S. Twillmann

Wegovy 2024 Updates

Susan Brian

Mounjaro Update 2024

Susan Brian

GLP-1 Hysteria

Scripps Health

S. Harris

New Research: Side Effect of GLP1

Susan Brian

Semaglutide: Where Are We Now and Where Are We Going?

McMaster University Department of Medicine

S. Boushahri, D. Lazzam, K. MacEachern

An Introduction to Tirzepatide for Weightloss

Susan Brian